Is this you? Create Your Porfile
Avatar

Mark Litton

Keck Graduate Institute of Applied Life Sciences

Network

Latest external collaboration on country level. Dive into details by clicking on the dots.

Explore More

Hotspot

Dive into the research topics where Mark Litton is active.

Explore More

Publication

Featured researches published by Mark Litton.

Archive | 2004

METHODS OF SYNTHESIZING HETEROMULTIMERIC POLYPEPTIDES IN YEAST USING A HAPLOID MATING STRATEGY

James M. Cregg; John Latham; Mark Litton; Randall Schatzman; Ilya Tolstorukov

Archive | 2011

Antagonists of il-6 to prevent or treat cachexia, weakness, fatigue, and/or fever

Jeffrey T. L. Smith; Randall Schatzman; Mark Litton; John A. Latham

Archive | 2009

Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

Leon F. Garcia-Martinez; Anne Elisabeth Carvalho Jensen; Katie Olson; Ben Dutzar; John A. Latham; Brian Kovacevich; Jeffrey T. L. Smith; Mark Litton; Randall Schatzman

Archive | 2017

Subcutaneously administrable composition containing anti-IL-6 antibody

Leon F. Garcia-Martinez; Anne Elisabeth Carvalho Jensen; Katie Anderson; Benjamin H. Dutzar; John A. Latham; Brian Kovacevich; Jeffrey T. L. Smith; Mark Litton; Randall Schatzman

Archive | 2017

Anti-IL-6 antibody for use in the treatment of cachexia

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman

Archive | 2015

***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman

Archive | 2014

***WITHDRAWN PATENT AS PER THE LATEST USPTO WITHDRAWN LIST***Methods of treating or diagnosing conditions associated with elevated IL-6 using anti-IL-6 antibodies or fragments

Leon F. Garcia-Martinez; Anne Elisabeth Carvalho Jensen; Katie Olson; Ben Dutzar; John A. Latham; Brian Kovacevich; Jeffrey T. L. Smith; Mark Litton; Randall Schatzman

Archive | 2012

Antagonists of IL-6 to treat cachexia, weakness, fatigue, and/or fever

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman

Archive | 2010

Antagonistes de l'il-6 destinés à prévenir ou à traiter la cachexie, la faiblesse, la fatigue, et/ou la fièvre

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman

Archive | 2010

Anti-IL-6 antibodies or fragments thereof to treat or inhibit cachexia, associated with chemotherapy toxicity

Jeffrey T. L. Smith; John A. Latham; Mark Litton; Randall Schatzman

Explore More

Collaboration

Dive into the Mark Litton's collaboration.

Top Co-Authors
Avatar

Randall Schatzman

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors
Avatar

Jeffrey T. L. Smith

University of Iowa

View shared research outputs
Top Co-Authors
Avatar

John A. Latham

University of Texas MD Anderson Cancer Center

View shared research outputs
Top Co-Authors
Avatar

Brian Kovacevich

University of Rochester

View shared research outputs
Top Co-Authors
Avatar

John Latham

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors
Avatar

Leon F. Garcia-Martinez

University of Iowa

View shared research outputs
Top Co-Authors
Avatar

Ilya Tolstorukov

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors
Avatar

James M. Cregg

Keck Graduate Institute of Applied Life Sciences

View shared research outputs
Top Co-Authors
Avatar

Benjamin H. Dutzar

University of Iowa

View shared research outputs
Explore More
Researchain Logo
Decentralizing Knowledge